WealthPlan Investment Management LLC Has $2.78 Million Stock Holdings in Synopsys, Inc. $SNPS

Key Points

• WealthPlan Investment Management LLC has increased its stock holdings in Synopsys, Inc. by 27.7%, now owning shares worth $2.78 million as of their most recent SEC filing.
• Several institutional investors have modified their positions in Synopsys, with a significant ownership of 85.47% of the company's stock now held by such investors.
• Analysts have issued mixed ratings on Synopsys, with a current average rating of "Hold" and an average price target of $569.67.

WealthPlan Investment Management LLC grew its holdings in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 27.7% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 5,426 shares of the semiconductor company's stock after purchasing an additional 1,177 shares during the period. WealthPlan Investment Management LLC's holdings in Synopsys were worth $2,782,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the business. Vanguard Group Inc. increased its stake in shares of Synopsys by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company's stock valued at $6,359,747,000 after purchasing an additional 346,994 shares during the last quarter. Pictet Asset Management Holding SA increased its stake in shares of Synopsys by 38.3% in the 1st quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company's stock valued at $1,043,518,000 after purchasing an additional 673,837 shares during the last quarter. Ameriprise Financial Inc. increased its stake in shares of Synopsys by 6.6% in the 1st quarter. Ameriprise Financial Inc. now owns 2,013,380 shares of the semiconductor company's stock valued at $863,500,000 after purchasing an additional 125,199 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in shares of Synopsys by 20.2% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company's stock valued at $778,928,000 after purchasing an additional 305,489 shares during the last quarter. Finally, Alliancebernstein L.P. increased its stake in shares of Synopsys by 22.2% in the 1st quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company's stock valued at $739,857,000 after purchasing an additional 313,218 shares during the last quarter. Institutional investors own 85.47% of the company's stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on SNPS. The Goldman Sachs Group decreased their price target on Synopsys from $700.00 to $600.00 and set a "buy" rating on the stock in a research note on Wednesday, September 10th. Morgan Stanley reduced their price objective on Synopsys from $715.00 to $510.00 and set an "overweight" rating on the stock in a research report on Thursday, September 11th. Wall Street Zen lowered Synopsys from a "hold" rating to a "sell" rating in a research report on Saturday, September 13th. JPMorgan Chase & Co. reduced their price objective on Synopsys from $685.00 to $600.00 and set an "overweight" rating on the stock in a research report on Wednesday, September 10th. Finally, Baird R W lowered Synopsys from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, September 10th. Ten investment analysts have rated the stock with a Buy rating, five have given a Hold rating and four have assigned a Sell rating to the company. According to data from MarketBeat, Synopsys presently has an average rating of "Hold" and an average price target of $569.67.

Synopsys Trading Down 1.8%

NASDAQ SNPS opened at $435.90 on Thursday. The business's 50-day moving average price is $532.75 and its two-hundred day moving average price is $510.07. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73. The firm has a market capitalization of $80.97 billion, a PE ratio of 34.22, a price-to-earnings-growth ratio of 4.89 and a beta of 1.10. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 EPS for the quarter, missing analysts' consensus estimates of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The company had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter last year, the firm posted $3.43 EPS. The company's quarterly revenue was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. On average, analysts expect that Synopsys, Inc. will post 10.64 EPS for the current year.

Insider Buying and Selling

In other news, CAO Sudhindra Kankanwadi sold 9,873 shares of the business's stock in a transaction dated Monday, September 22nd. The stock was sold at an average price of $500.90, for a total value of $4,945,385.70. Following the transaction, the chief accounting officer directly owned 20,520 shares of the company's stock, valued at $10,278,468. The trade was a 32.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Shelagh Glaser sold 3,655 shares of the business's stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $609.77, for a total value of $2,228,709.35. Following the completion of the transaction, the chief financial officer directly owned 15,317 shares in the company, valued at $9,339,847.09. This represents a 19.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 30,894 shares of company stock worth $16,760,783. Corporate insiders own 0.62% of the company's stock.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.